7 Colorful Bowl Recipes You Can Make in Under 10 Minutes
If you're looking for an easy way to eat more fruits and vegetables, start with a bowl. Bowls are one of the...
September 02, 2026
For men diagnosed with prostate cancer, one number can suddenly take on enormous importance: PSA.
Prostate-specific antigen, or PSA, is a protein produced by prostate cells. PSA testing plays an important role in detecting prostate cancer and in monitoring men after diagnosis or treatment. When PSA rises, it can understandably create concern. And when it falls, it can feel like reassurance.
That raises an intriguing question:
Can changing the way you eat change your PSA?
Research conducted over the past two decades suggests that diet and lifestyle may influence the biological environment surrounding prostate cancer. Some studies have reported favorable changes in PSA, while newer research has associated diets richer in plant foods with a lower risk of prostate cancer progression.
But the science deserves some nuance.
A plant-based diet should not be presented as a treatment for prostate cancer or as a replacement for active surveillance, surgery, radiation, medication, or other medical care. And PSA is not itself a direct measurement of tumor size.
What the evidence does tell us is worth understanding.
PSA is produced by both normal and malignant prostate cells. Higher PSA levels can be associated with prostate cancer, but cancer is not the only reason PSA may rise.
Benign prostate enlargement, inflammation or infection of the prostate, certain procedures and medications, and even ordinary biological variation can influence PSA. For that reason, there is no single PSA number that definitively determines whether prostate cancer is present or progressing.
For someone who has already been diagnosed with prostate cancer, physicians may look at PSA alongside other information such as biopsy findings, Grade Group or Gleason score, imaging, tumor characteristics and changes over time.
That is especially important for men on active surveillance, where regular PSA testing and repeat evaluation are used to monitor the cancer and determine whether treatment becomes necessary.
So when we talk about nutrition and PSA, we need to remember:
PSA is an important biomarker, but it is only one piece of the prostate cancer picture.
One of the most frequently cited studies examining lifestyle and prostate cancer was published by Dean Ornish, MD, and colleagues in The Journal of Urology in 2005.
Researchers enrolled 93 men with early-stage prostate cancer who had chosen active surveillance rather than immediate conventional treatment.
They were randomized into two groups.
The intervention group adopted an intensive lifestyle program that included:
The program also included several nutritional supplements, meaning this was not a trial of diet alone.
After one year, the difference between the groups was notable.
Average PSA decreased approximately 4% in the lifestyle group while increasing approximately 6% in the usual-care group. The difference between the groups was statistically significant.
Researchers also conducted an interesting laboratory experiment. They exposed prostate cancer cells to blood serum taken from participants.
Serum from the lifestyle-intervention group inhibited the growth of prostate cancer cells substantially more than serum from the control group.
That does not mean a person's blood was proven to stop cancer inside the body. Laboratory experiments and human clinical outcomes are very different things. But the finding strengthened the researchers' hypothesis that major lifestyle changes could alter biological conditions relevant to tumor growth.
Most importantly, because participants changed diet, exercise, stress management and other factors simultaneously, researchers could not determine how much of the PSA difference was caused specifically by food.
Still, the results challenged the assumption that lifestyle was irrelevant once prostate cancer had already been diagnosed.
The same researchers followed participants for two years.
By that point, 13 of 49 men in the control group had undergone conventional prostate cancer treatment compared with 2 of 43 men in the intensive lifestyle group.
That finding is interesting, but it requires caution. Decisions to move from active surveillance to treatment can be influenced by several clinical and personal factors, and this was a relatively small study.
It does, however, add another piece of evidence suggesting that lifestyle may deserve serious consideration as part of comprehensive prostate cancer care.
Perhaps even more compelling than asking whether plant foods change an individual PSA reading is asking whether dietary patterns are associated with what happens to the cancer over time.
A major study published in JAMA Network Open in 2024 followed 2,062 men with nonmetastatic prostate cancer.
Researchers scored participants according to how strongly their diets emphasized plant foods.
Over a median follow-up of 6.5 years, men in the highest fifth of overall plant-based diet scores had a:
47% lower risk of prostate cancer progression compared with men in the lowest fifth.
The hazard ratio was 0.53 (95% CI, 0.37–0.74).
Importantly, "progression" was not simply defined as a small movement in PSA. The study's composite outcome included biochemical recurrence, secondary treatment, bone metastasis or death attributed to prostate cancer. Most progression events in the cohort were biochemical recurrences.
Among men who had been diagnosed with Gleason grade 7 or higher disease, those with the highest scores on a healthful plant-based diet index also had a 55% lower risk of progression than those with the lowest scores.
These are striking numbers.
But they come from an observational study, not a randomized trial. That means researchers can demonstrate an association, but they cannot prove that eating more plant foods caused the reduction in progression.
People who eat differently may also exercise differently, maintain different body weights, receive different medical care or have other characteristics that influence outcomes. Researchers adjust statistically for many of these variables, but residual confounding is always possible.
The evidence is encouraging, but it is not perfectly consistent.
A systematic review of plant-based diets and prostate cancer identified 32 eligible publications, including five intervention studies and 11 observational studies.
The authors concluded that lifestyle interventions incorporating plant-based diets generally produced favorable short-term prostate cancer outcomes, while observational research found either beneficial associations or no significant association. They also emphasized an important limitation: we still need better data on long-term, disease-specific outcomes.
A newer systematic review examining dietary patterns across 63 studies reached a similarly measured conclusion. Among men already diagnosed with prostate cancer, plant-based, Mediterranean and lower-inflammatory dietary patterns were more consistently associated with lower risks of progression and prostate cancer-specific mortality. But randomized trials examining PSA and other tumor markers have produced mixed results.
That distinction matters.
The responsible interpretation is not:
"A plant-based diet lowers PSA and stops prostate cancer."
The evidence supports something more nuanced:
Plant-forward dietary patterns may be associated with a more favorable course of disease, and intensive lifestyle intervention has produced favorable PSA changes in at least one randomized trial. But the evidence is not yet strong enough to promise that changing diet will lower any individual's PSA or prevent prostate cancer from progressing.
Researchers are still working to understand which components of diet may matter most.
A whole-food, plant-predominant diet naturally changes many things at once. It generally increases intake of fiber, vegetables, fruits, whole grains, legumes and numerous phytochemicals while reducing exposure to foods high in saturated fat and highly processed ingredients.
It can also influence weight and overall cardiometabolic health.
That last point should not be overlooked.
Men with prostate cancer often live for many years after diagnosis, making cardiovascular and metabolic health enormously important alongside cancer-specific health. Cancer survivorship recommendations therefore emphasize maintaining a healthy weight, being physically active and eating a dietary pattern rich in vegetables, fruits, whole grains and legumes while limiting red and processed meats, sugary drinks and highly processed foods.
The World Cancer Research Fund similarly recommends making whole grains, vegetables, fruits and beans a major part of the diet and encourages cancer survivors, when possible, to follow its cancer-prevention recommendations.
So even while researchers continue investigating prostate-cancer-specific effects, eating this way can support health well beyond the prostate.
This may be the most important practical point.
PSA can fluctuate.
Prostate inflammation, benign prostate enlargement and other factors can raise the number. Some medications can lower it. Biological variability also occurs from one measurement to another.
A declining PSA after changing your diet may be encouraging, but it should not be interpreted on its own as proof that a tumor is shrinking.
Likewise, a rising PSA does not mean someone "failed" at eating well.
PSA results need to be interpreted by a clinician in the context of the individual's diagnosis, treatment history, imaging, pathology and previous PSA measurements.
And anyone undergoing active surveillance should continue the surveillance schedule recommended by their medical team. Diet is not a substitute for appropriate cancer monitoring.
Fortunately, the dietary pattern being studied is remarkably familiar.
Build most meals around:
Vegetables
Leafy greens, broccoli, cauliflower, cabbage, carrots, peppers, tomatoes and other colorful vegetables.
Legumes
Beans, lentils, chickpeas and peas provide plant protein along with fiber and a wide range of nutrients.
Whole grains
Oats, barley, brown rice, quinoa, farro and other intact whole grains.
Whole fruits
Berries, citrus, apples, pears, grapes and other fruit.
Nuts and seeds
When appropriate for an individual's dietary needs, they provide additional plant protein, minerals and other nutrients.
And reduce the space given to highly processed foods, refined grains, sugar-sweetened beverages and red and processed meats.
That is exactly the kind of gap Plant Strong Foods was created to fill. Our products are built around whole plant ingredients, whole grains, legumes, fruits and vegetables, with no added oils, no refined sugar and no excessive sodium, making it easier to choose foods that align with those principles in everyday life.
It isn't about discovering one "prostate superfood."
It is about changing the dietary pattern.
Twenty years ago, a small randomized trial produced a provocative finding: men with early prostate cancer who made intensive lifestyle changes experienced a modest decline in PSA while PSA rose in men receiving usual care.
Today, we have additional evidence suggesting that diets richer in plant foods may be associated with a lower risk of prostate cancer progression.
We still don't have enough evidence to say that a plant-based diet will lower PSA in every man, reverse prostate cancer or eliminate the need for treatment.
But we also have enough evidence to take nutrition seriously.
For someone living with prostate cancer, filling the plate with vegetables, fruits, whole grains, beans and other minimally processed plant foods can be one powerful way to support overall health while continuing appropriate medical treatment and surveillance.
You may not be able to control every number on a pathology report.
But every day, you still get to decide what goes on your plate.